BiotechTube
Home/Moberg Pharma/Anna Ljung
AL

Anna Ljung

Chief Executive Officer

Moberg Pharma

Therapeutic Areas

DermatologyInfectious Disease

Moberg Pharma Pipeline

DrugIndicationPhase
MOB-015Onychomycosis (Toenail Fungus)Marketed

Leadership Team at Moberg Pharma

PW
Peter Wolpert
Founder and Board Member
CG
Claes G. Wahlestedt
Board Member
View full Moberg Pharma profile